Journal of Molecular Biomarkers & Diagnosis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
Fei Ye
Fei Ye

Fei Ye
Department of Pathology
Mount Sinai School of Medicine


Dr. Ye’s presently working in the department of Pathology, Mount Sinai School of Mediicne, USA. Research work had been focus on plant-derived agents and their anti-cancer activity and their molecular mechanism since 1995.

Research Interest

Dr. Ye’s research work had been focus on plant-derived agents and their anti-cancer activity and their molecular mechanism since 1995. One such drug, SBX, can inhibit NSCLC cell growth in vitro and in animals, and SBX directly targets the ERK pathway. More significantly, SBX is more potent and much tolerable than carboplatin, a most effective drug for NSCLC. Combination of SBX with carboplatin can synergistically increase the potency of their anticancer activity, probably acting cooperatively on different anti-proliferation mechanisms. Dr. Ye Also has a strong interest in drug and diagnostic marker discovery. In order for searching biomarkers and drugable targets for cancer diagnosis and treatment, Dr. Ye recently developed a novel Protein Pathway Array Technology ( The Pathway Array technology is an innovative proteomic assay that allows screen globally the changes in protein expression and phosphorylation. The focus of Protein Pathway Array is to determine the signaling networks that related to proliferation, apoptosis, angiogenesis, invasion and metastasis. Using this technology, Dr. Ye and her group identified several promising protein biomarkers for cancer diagnosis, molecular staging and prognosis.


Global Speakers in the subject

Global Experts in the subject


Detection of Mitochondrial Mutations in Cancer by Next Generation Sequencing

Fei Ye, David C, Samuels and Yan Guo

Review Article: Next Generat Sequenc & Applic 2014,1: 102
doi: 10.4172/2469-9853.1000102
Proteomic Approaches for Profiling Cancer Signaling Pathways

Fei Ye and David Y. Zhang

Editorial: J Mol Biomark Diagn 2012, 3: e104
doi: 10.4172/2155-9929.1000e104

türk porno izletürk pornoları doyasıya izleyin ve boşalın.

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version